chr12-101157304-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145913.5(SLC5A8):c.1808G>A(p.Gly603Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,613,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145913.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A8 | NM_145913.5 | c.1808G>A | p.Gly603Asp | missense_variant | 15/15 | ENST00000536262.3 | NP_666018.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A8 | ENST00000536262.3 | c.1808G>A | p.Gly603Asp | missense_variant | 15/15 | 1 | NM_145913.5 | ENSP00000445340 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151932Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250932Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135620
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461216Hom.: 0 Cov.: 31 AF XY: 0.0000592 AC XY: 43AN XY: 726884
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151932Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74178
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.1808G>A (p.G603D) alteration is located in exon 15 (coding exon 15) of the SLC5A8 gene. This alteration results from a G to A substitution at nucleotide position 1808, causing the glycine (G) at amino acid position 603 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at